Kolexia
Yrondi Antoine
Psychiatrie
Hôpital Purpan
Toulouse, France
181 Activités
478 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Épilepsie Urgences Inflammation Crises épileptiques Épuisement professionnel Infections à coronavirus Pneumopathie virale Crises non épileptiques psychogènes

Industries

Janssen
17 collaboration(s)
Dernière en 2022
GW Research Limited
2 collaboration(s)
Dernière en 2022
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Withdrawal syndrome after antipsychotics discontinuation: an analysis of the WHO database of spontaneous reports (Vigibase) between 2000 and 2022.
Psychopharmacology   20 février 2024
French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024.
L'Encephale   17 février 2024
Structural and functional changes associated with functional/dissociative seizures: A review of the literature.
Epilepsy & behavior : E&B   28 janvier 2024
Older adults in psychedelic-assisted therapy trials: A systematic review.
Journal of psychopharmacology (Oxford, England)   19 janvier 2024
Drug-induced depressive symptoms: An update through the WHO pharmacovigilance database.
Journal of affective disorders   18 janvier 2024
Correction: Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression.
Molecular psychiatry   05 décembre 2023
Funding of psychiatry in France, the problem of expensive drugs. Example of Esketamine in the case of resistant depressive episodes.
L'Encephale   30 novembre 2023
Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression.
Molecular psychiatry   20 novembre 2023
Indirect effect of impulsivity on suicide risk through self-esteem and depressive symptoms in a population with treatment-resistant depression: A FACE-DR study.
Journal of affective disorders   20 novembre 2023
Evolution of Cognitive Impairments in Treatment-Resistant Depression: Results from the Longitudinal French Centers of Expertise for Treatment-Resistant Depression (FACE-DR) Cohort.
Brain sciences   24 juillet 2023